Inogen Stock News

Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported a fourth-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier. The Goleta, California-based company sai

GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported a fourth-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier. The Goleta, California-based company sa

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-mont

Inogen (NASDAQ:INGN) is scheduled to announce Q4 earnings results on Tuesday, February 25th, after market close.The consensus EPS Estimate is $0.09 (-79.5% Y/Y) and the consensus Revenue Estimate is $

If you own shares in Inogen, Inc. (NASDAQ:INGN) then it's worth thinking about how it contributes to the volatility of...

If you're interested in Inogen, Inc. (NASDAQ:INGN), then you might want to consider its beta (a measure of share price...

Inogen (NASDAQ:INGN) is set to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.11 per share for the quarter. Inv

Rockefeller Capital Management L.P. boosted its holdings in shares of Inogen Inc (NASDAQ:INGN) by 0.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchan

Dublin, Feb. 21, 2020 -- The "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering..

The "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

Inogen, Inc. (INGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Inogen, Inc. (INGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.